Hematopoietic Stem Cells VII, Volume 1176
Eds.: Kanz, Lothar, Dick, John E., Fibbe, Willem E. et al.
Hematopoietic Stem Cells VII, Volume 1176
Eds.: Kanz, Lothar, Dick, John E., Fibbe, Willem E. et al.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
A fundamental property of hematopoetic stem cells is their capacity to self-renew, thus providing, in principle, a limitless source of daughter cells and with the same functional properties. This volume presents the most recent developments, and their clinical implications, in hematopoietic stem cell research. The field of hematopoietic stem cell biology is rapidly advancing and new ideas and concepts supported by new technologies provide new discoveries. Topics covered are genetic and epigenetic regulation of stem cells, stem cell plasticity, stem cell regulation and self-renewal, and…mehr
Andere Kunden interessierten sich auch für
- Jonathan M. W. SlackThe Science of Stem Cells115,99 €
- Oxidative / Nitrosative Stress and Disease, Volume 1203151,99 €
- Robert A. BrownExtreme Tissue Engineering105,99 €
- Marcy A. KellyThe Fundamentals of Scientific Research57,99 €
- Ribosome-Inactivating Proteins164,99 €
- Mitochondrial Research in Translational Medicine, Volume 1201151,99 €
- Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism180,99 €
-
-
-
A fundamental property of hematopoetic stem cells is their capacity to self-renew, thus providing, in principle, a limitless source of daughter cells and with the same functional properties. This volume presents the most recent developments, and their clinical implications, in hematopoietic stem cell research. The field of hematopoietic stem cell biology is rapidly advancing and new ideas and concepts supported by new technologies provide new discoveries. Topics covered are genetic and epigenetic regulation of stem cells, stem cell plasticity, stem cell regulation and self-renewal, and embryonic stem cells as well as malignant stem cell biology.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit for more information about becoming a member.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit for more information about becoming a member.
Produktdetails
- Produktdetails
- Annals of the New York Academy of Sciences Vol.1176
- Verlag: Wiley & Sons
- Artikelnr. des Verlages: 1A573317610
- 1. Auflage
- Seitenzahl: 300
- Erscheinungstermin: 26. Oktober 2009
- Englisch
- Abmessung: 253mm x 178mm x 15mm
- Gewicht: 507g
- ISBN-13: 9781573317610
- ISBN-10: 1573317616
- Artikelnr.: 26885249
- Annals of the New York Academy of Sciences Vol.1176
- Verlag: Wiley & Sons
- Artikelnr. des Verlages: 1A573317610
- 1. Auflage
- Seitenzahl: 300
- Erscheinungstermin: 26. Oktober 2009
- Englisch
- Abmessung: 253mm x 178mm x 15mm
- Gewicht: 507g
- ISBN-13: 9781573317610
- ISBN-10: 1573317616
- Artikelnr.: 26885249
Lothar Kanz is the editor of Hematopoietic Stem Cells VII, Volume 1176, published by Wiley. John Edgar Dick FRS FRSC is Canada Research Chair in Stem Cell Biology, Senior Scientist at the Princess Margaret Cancer Centre, University Health Network and Professor in the Department of Molecular Genetics at the University of Toronto in Canada.
Part I. Stem Cell Hierachy and Niche. 1. Lymphoid lineage fate decision of hematopoietic stem cells (Koichi Akashi). 2. Genetic Models to Study Quiescent Stem Cells and Their Niches (Christoph Schaniel and Kateri A. Moore). 3. Niche regulation of hematopoietic stem cells in the endosteum: the role of Thrombopoietin/Mpl signaling in the maintenance of quiescent hematopoietic stem cells (Fumio Arai
Hiroki Yoshihara
Kentaro Hosokawa
Yuka Nakamura
Yumiko Gomei
Hiroko Iwasaki
and Toshio Suda). 4. Functional Heterogeneity of the Bone Marrow Vascular Niche (K. Hans Georg Kopp
Andrea T. Hooper
Scott T. Avecilla
and Shahin Rafii). Part II. Stem Cell Regulation. 5. Complex and Context Dependent Regulation of Hematopoiesis by TGF-' Superfamily Signaling (Sofie Singbrant Söderberg
Göran Karlsson
and Stefan Karlsson). 6. WNT Proteins: Environmental factors regulating HSC fate in the niche (Tiago C. Luis and Frank J.T. Staal). 7. Removal of the Spleen in Mice Alters the Cytokine Expression Profile of the Marrow Microenvironmement and Increases Bone Formation (Fabrizio Martelli
Maria Verrucci
Giovanni Migliaccio
Maria Zingariello
Rosa Alba Rana
Alessandro Maria Vannucchi
and Anna Rita Migliaccio). 8. Novel trafficking routes for hematopoietic stem and progenitor cells (Steffen Massberg and Ulrich H. von Andrian). 9. Dysregulation of myeloid-specific transcription factors in congenital neutropenia: rescue by NAMPT/NAD+/SIRT1 (Julia Skokowa and Karl Welte). Part III. Mesenchymal Stem Cells. 10. Mesenchymal stromal cells: a novel treatment modality for tissue repair (Maria Ester Bernardo
Franco Locatelli
and Willem E. Fibbe). 11. Perivascular Multipotent Progenitor Cells in Human Organs (Mihaela Crisan
Chien-Wen Chen
Mirko Corselli
Gabriella Andriolo
Lorenza Lazzari
and Bruno Péault). 12. Phenotypic characterization of distinct human bone marrow-derived MSC subsets (Hans-Jörg Bühring
Sabrina Treml
Flavianna Cerabona
Peter de Zwart
Lothar Kanz
and Malgorzata Sobiesiak). 13. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair (Adriana C. Drost
Sibylle Weng
Gerhard Feil
Jochen Schäfer
Simon Baumann
Lothar Kanz
Karl-Dietrich Sievert
Arnulf Stenzl
and Robert Möhle). Part IV. Malignant Hematopoiesis and Cancer Stem Cells. 14. Transformation from Committed Progenitor To Leukemia Stem Cells (Andrei V. Krivtsov
Zhaohui Feng
and Scott A. Armstrong). 15. The role of PLZF in human myeloid development (John E. Dick and Sergei Doulatov). 16. Anti-Tumor Immunity and Cancer Stem Cells (Tobias Schatton and Markus H. Frank). 17. Natural genetic diversity as a means to uncover stem cell regulatory pathways (Gary Van Zant and Ying Liang). Part V. Aging. 18. Short Telomeres Resulting from Heritable Mutations in the Telomerase Reverse Transcriptase Gene Predispose for a Variety of Malignancies (Mark Hills and Peter M. Lansdorp). Part V. Pluripotency. 19. Disease models from pluripotent stem cells: turning back time in disease pathogenesis? (Claudia Lengerke and George Q. Daley). 20. Tumors originating from induced pluripotent stem cells and methods for their prevention (Dirk Duinsbergen
Daniela Salvatori
Malin Eriksson
and Harald Mikkers). 21. Fetal Liver Very Small Embryonic/Epiblast Like Stem Cells (VSELs) Follow Developmental Migratory Pathway of Hematopoietic Stem Cells (Ewa K. Zuba-Surma
Magda Kucia
Liu Rui
Wojtek Wojakowski
Janina Ratajczak
and Mariusz Z. Ratajczak). 22. Hematopoietic Development from Human Induced Pluripotent Stem Cells (Claudia Lengerke
Matthias Grauer
Nina I. Niebuhr
Tamara Riedt
Lothar Kanz
In-Hyun Park
and George Q. Daley).
Hiroki Yoshihara
Kentaro Hosokawa
Yuka Nakamura
Yumiko Gomei
Hiroko Iwasaki
and Toshio Suda). 4. Functional Heterogeneity of the Bone Marrow Vascular Niche (K. Hans Georg Kopp
Andrea T. Hooper
Scott T. Avecilla
and Shahin Rafii). Part II. Stem Cell Regulation. 5. Complex and Context Dependent Regulation of Hematopoiesis by TGF-' Superfamily Signaling (Sofie Singbrant Söderberg
Göran Karlsson
and Stefan Karlsson). 6. WNT Proteins: Environmental factors regulating HSC fate in the niche (Tiago C. Luis and Frank J.T. Staal). 7. Removal of the Spleen in Mice Alters the Cytokine Expression Profile of the Marrow Microenvironmement and Increases Bone Formation (Fabrizio Martelli
Maria Verrucci
Giovanni Migliaccio
Maria Zingariello
Rosa Alba Rana
Alessandro Maria Vannucchi
and Anna Rita Migliaccio). 8. Novel trafficking routes for hematopoietic stem and progenitor cells (Steffen Massberg and Ulrich H. von Andrian). 9. Dysregulation of myeloid-specific transcription factors in congenital neutropenia: rescue by NAMPT/NAD+/SIRT1 (Julia Skokowa and Karl Welte). Part III. Mesenchymal Stem Cells. 10. Mesenchymal stromal cells: a novel treatment modality for tissue repair (Maria Ester Bernardo
Franco Locatelli
and Willem E. Fibbe). 11. Perivascular Multipotent Progenitor Cells in Human Organs (Mihaela Crisan
Chien-Wen Chen
Mirko Corselli
Gabriella Andriolo
Lorenza Lazzari
and Bruno Péault). 12. Phenotypic characterization of distinct human bone marrow-derived MSC subsets (Hans-Jörg Bühring
Sabrina Treml
Flavianna Cerabona
Peter de Zwart
Lothar Kanz
and Malgorzata Sobiesiak). 13. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair (Adriana C. Drost
Sibylle Weng
Gerhard Feil
Jochen Schäfer
Simon Baumann
Lothar Kanz
Karl-Dietrich Sievert
Arnulf Stenzl
and Robert Möhle). Part IV. Malignant Hematopoiesis and Cancer Stem Cells. 14. Transformation from Committed Progenitor To Leukemia Stem Cells (Andrei V. Krivtsov
Zhaohui Feng
and Scott A. Armstrong). 15. The role of PLZF in human myeloid development (John E. Dick and Sergei Doulatov). 16. Anti-Tumor Immunity and Cancer Stem Cells (Tobias Schatton and Markus H. Frank). 17. Natural genetic diversity as a means to uncover stem cell regulatory pathways (Gary Van Zant and Ying Liang). Part V. Aging. 18. Short Telomeres Resulting from Heritable Mutations in the Telomerase Reverse Transcriptase Gene Predispose for a Variety of Malignancies (Mark Hills and Peter M. Lansdorp). Part V. Pluripotency. 19. Disease models from pluripotent stem cells: turning back time in disease pathogenesis? (Claudia Lengerke and George Q. Daley). 20. Tumors originating from induced pluripotent stem cells and methods for their prevention (Dirk Duinsbergen
Daniela Salvatori
Malin Eriksson
and Harald Mikkers). 21. Fetal Liver Very Small Embryonic/Epiblast Like Stem Cells (VSELs) Follow Developmental Migratory Pathway of Hematopoietic Stem Cells (Ewa K. Zuba-Surma
Magda Kucia
Liu Rui
Wojtek Wojakowski
Janina Ratajczak
and Mariusz Z. Ratajczak). 22. Hematopoietic Development from Human Induced Pluripotent Stem Cells (Claudia Lengerke
Matthias Grauer
Nina I. Niebuhr
Tamara Riedt
Lothar Kanz
In-Hyun Park
and George Q. Daley).
Part I. Stem Cell Hierachy and Niche. 1. Lymphoid lineage fate decision of hematopoietic stem cells (Koichi Akashi). 2. Genetic Models to Study Quiescent Stem Cells and Their Niches (Christoph Schaniel and Kateri A. Moore). 3. Niche regulation of hematopoietic stem cells in the endosteum: the role of Thrombopoietin/Mpl signaling in the maintenance of quiescent hematopoietic stem cells (Fumio Arai
Hiroki Yoshihara
Kentaro Hosokawa
Yuka Nakamura
Yumiko Gomei
Hiroko Iwasaki
and Toshio Suda). 4. Functional Heterogeneity of the Bone Marrow Vascular Niche (K. Hans Georg Kopp
Andrea T. Hooper
Scott T. Avecilla
and Shahin Rafii). Part II. Stem Cell Regulation. 5. Complex and Context Dependent Regulation of Hematopoiesis by TGF-' Superfamily Signaling (Sofie Singbrant Söderberg
Göran Karlsson
and Stefan Karlsson). 6. WNT Proteins: Environmental factors regulating HSC fate in the niche (Tiago C. Luis and Frank J.T. Staal). 7. Removal of the Spleen in Mice Alters the Cytokine Expression Profile of the Marrow Microenvironmement and Increases Bone Formation (Fabrizio Martelli
Maria Verrucci
Giovanni Migliaccio
Maria Zingariello
Rosa Alba Rana
Alessandro Maria Vannucchi
and Anna Rita Migliaccio). 8. Novel trafficking routes for hematopoietic stem and progenitor cells (Steffen Massberg and Ulrich H. von Andrian). 9. Dysregulation of myeloid-specific transcription factors in congenital neutropenia: rescue by NAMPT/NAD+/SIRT1 (Julia Skokowa and Karl Welte). Part III. Mesenchymal Stem Cells. 10. Mesenchymal stromal cells: a novel treatment modality for tissue repair (Maria Ester Bernardo
Franco Locatelli
and Willem E. Fibbe). 11. Perivascular Multipotent Progenitor Cells in Human Organs (Mihaela Crisan
Chien-Wen Chen
Mirko Corselli
Gabriella Andriolo
Lorenza Lazzari
and Bruno Péault). 12. Phenotypic characterization of distinct human bone marrow-derived MSC subsets (Hans-Jörg Bühring
Sabrina Treml
Flavianna Cerabona
Peter de Zwart
Lothar Kanz
and Malgorzata Sobiesiak). 13. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair (Adriana C. Drost
Sibylle Weng
Gerhard Feil
Jochen Schäfer
Simon Baumann
Lothar Kanz
Karl-Dietrich Sievert
Arnulf Stenzl
and Robert Möhle). Part IV. Malignant Hematopoiesis and Cancer Stem Cells. 14. Transformation from Committed Progenitor To Leukemia Stem Cells (Andrei V. Krivtsov
Zhaohui Feng
and Scott A. Armstrong). 15. The role of PLZF in human myeloid development (John E. Dick and Sergei Doulatov). 16. Anti-Tumor Immunity and Cancer Stem Cells (Tobias Schatton and Markus H. Frank). 17. Natural genetic diversity as a means to uncover stem cell regulatory pathways (Gary Van Zant and Ying Liang). Part V. Aging. 18. Short Telomeres Resulting from Heritable Mutations in the Telomerase Reverse Transcriptase Gene Predispose for a Variety of Malignancies (Mark Hills and Peter M. Lansdorp). Part V. Pluripotency. 19. Disease models from pluripotent stem cells: turning back time in disease pathogenesis? (Claudia Lengerke and George Q. Daley). 20. Tumors originating from induced pluripotent stem cells and methods for their prevention (Dirk Duinsbergen
Daniela Salvatori
Malin Eriksson
and Harald Mikkers). 21. Fetal Liver Very Small Embryonic/Epiblast Like Stem Cells (VSELs) Follow Developmental Migratory Pathway of Hematopoietic Stem Cells (Ewa K. Zuba-Surma
Magda Kucia
Liu Rui
Wojtek Wojakowski
Janina Ratajczak
and Mariusz Z. Ratajczak). 22. Hematopoietic Development from Human Induced Pluripotent Stem Cells (Claudia Lengerke
Matthias Grauer
Nina I. Niebuhr
Tamara Riedt
Lothar Kanz
In-Hyun Park
and George Q. Daley).
Hiroki Yoshihara
Kentaro Hosokawa
Yuka Nakamura
Yumiko Gomei
Hiroko Iwasaki
and Toshio Suda). 4. Functional Heterogeneity of the Bone Marrow Vascular Niche (K. Hans Georg Kopp
Andrea T. Hooper
Scott T. Avecilla
and Shahin Rafii). Part II. Stem Cell Regulation. 5. Complex and Context Dependent Regulation of Hematopoiesis by TGF-' Superfamily Signaling (Sofie Singbrant Söderberg
Göran Karlsson
and Stefan Karlsson). 6. WNT Proteins: Environmental factors regulating HSC fate in the niche (Tiago C. Luis and Frank J.T. Staal). 7. Removal of the Spleen in Mice Alters the Cytokine Expression Profile of the Marrow Microenvironmement and Increases Bone Formation (Fabrizio Martelli
Maria Verrucci
Giovanni Migliaccio
Maria Zingariello
Rosa Alba Rana
Alessandro Maria Vannucchi
and Anna Rita Migliaccio). 8. Novel trafficking routes for hematopoietic stem and progenitor cells (Steffen Massberg and Ulrich H. von Andrian). 9. Dysregulation of myeloid-specific transcription factors in congenital neutropenia: rescue by NAMPT/NAD+/SIRT1 (Julia Skokowa and Karl Welte). Part III. Mesenchymal Stem Cells. 10. Mesenchymal stromal cells: a novel treatment modality for tissue repair (Maria Ester Bernardo
Franco Locatelli
and Willem E. Fibbe). 11. Perivascular Multipotent Progenitor Cells in Human Organs (Mihaela Crisan
Chien-Wen Chen
Mirko Corselli
Gabriella Andriolo
Lorenza Lazzari
and Bruno Péault). 12. Phenotypic characterization of distinct human bone marrow-derived MSC subsets (Hans-Jörg Bühring
Sabrina Treml
Flavianna Cerabona
Peter de Zwart
Lothar Kanz
and Malgorzata Sobiesiak). 13. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair (Adriana C. Drost
Sibylle Weng
Gerhard Feil
Jochen Schäfer
Simon Baumann
Lothar Kanz
Karl-Dietrich Sievert
Arnulf Stenzl
and Robert Möhle). Part IV. Malignant Hematopoiesis and Cancer Stem Cells. 14. Transformation from Committed Progenitor To Leukemia Stem Cells (Andrei V. Krivtsov
Zhaohui Feng
and Scott A. Armstrong). 15. The role of PLZF in human myeloid development (John E. Dick and Sergei Doulatov). 16. Anti-Tumor Immunity and Cancer Stem Cells (Tobias Schatton and Markus H. Frank). 17. Natural genetic diversity as a means to uncover stem cell regulatory pathways (Gary Van Zant and Ying Liang). Part V. Aging. 18. Short Telomeres Resulting from Heritable Mutations in the Telomerase Reverse Transcriptase Gene Predispose for a Variety of Malignancies (Mark Hills and Peter M. Lansdorp). Part V. Pluripotency. 19. Disease models from pluripotent stem cells: turning back time in disease pathogenesis? (Claudia Lengerke and George Q. Daley). 20. Tumors originating from induced pluripotent stem cells and methods for their prevention (Dirk Duinsbergen
Daniela Salvatori
Malin Eriksson
and Harald Mikkers). 21. Fetal Liver Very Small Embryonic/Epiblast Like Stem Cells (VSELs) Follow Developmental Migratory Pathway of Hematopoietic Stem Cells (Ewa K. Zuba-Surma
Magda Kucia
Liu Rui
Wojtek Wojakowski
Janina Ratajczak
and Mariusz Z. Ratajczak). 22. Hematopoietic Development from Human Induced Pluripotent Stem Cells (Claudia Lengerke
Matthias Grauer
Nina I. Niebuhr
Tamara Riedt
Lothar Kanz
In-Hyun Park
and George Q. Daley).